PRDX2 and hepatocellular carcinoma: First, to link the antioxidant function of PRDX2 to HCC initiation, we generated a mutation in the PRDX2 catalytic site by substituting the peroxidatic cysteine residue (Cp) by a serine (C51S), resulting in peroxidase inactive mutant expression (Figure 6A) (48).